Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an unexpected higher risk of mother-to-child transmission (MTCT) of HIV among HIV-positive women receiving MQ has also been observed. To determine if inter...

Full description

Saved in:
Bibliographic Details
Published in:AIDS Res Hum Retroviruses
Main Authors: Haaland, Richard E., Otieno, Kephas, Martin, Amy, Katana, Abraham, Dinh, Chuong, Slutsker, Laurence, Menendez, Clara, Gonzalez, Raquel, Williamson, John, Heneine, Walid, Desai, Meghna
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc., publishers 2018
Subjects:
Clinical Trial
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238614/
https://ncbi.nlm.nih.gov/pubmed/30173559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2018.0042
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items